Proxima's Quarterly Convening

​🎉 Proxima's signature Quarterly Convening brings together members and non-members alike from the broader healthcare community in NYC.

🎊 For our annual holiday gathering, we're thrilled to welcome Gavin Corcoran, Executive In Residence at Formation Bio, as our esteemed guest speaker to discuss AI in Clinical Development.

​🔬 AI in Clinical Development: A Conversation with Gavin Corcoran

​AI has produced far more drug candidates than the industry has capital to develop. The unintended consequence of AI driven discovery is that we have more molecules to develop and so far, there's no evidence AI-discovered molecules succeed in clinical trials at a higher rate than molecules found the old way. Therefore, the bottleneck in drug development remains the clinical development of the molecules.

​Join us for the next Proxima Quarterly Convening with Gavin Corcoran, Executive in Residence at Formation Bio. Gavin will discuss where he thinks AI actually earns its keep in drug development right now, and why Formation Bio has built its approach around clinical development rather than discovery. We'll get into the open question underneath: does AI level the playing field between biotech and big pharma, or just raise the price of admission.

🍸 Join us for an evening of drinks, merriment, and even better company.